Abstract
To clarify the question of whether Guillain-Barre syndrome (GBS) patients treated with intravenous immune globulin (IVIG) relapse at a higher frequency than those treated with plasma exchange (PE), 54 patients with GBS were studied retrospectively. A higher frequency of relapses was noted in the PE-treated patients than in those receiving IVIG. The presence of an associated medical condition correlated with an increased risk of relapses, while earlier onset of treatment resulted in a decrease of relapses of GBS. This study found no support for prior suggestions of increased relapses in patients with GBS treated with IVIG as opposed to those treated with PE.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1327-1330 |
| Number of pages | 4 |
| Journal | Muscle and Nerve |
| Volume | 21 |
| Issue number | 10 |
| DOIs | |
| State | Published - Sep 12 1998 |
Fingerprint
Keywords
- Guillain-Barre syndrome
- Intravenous immune globulin
- Plasma exchange
- Relapses
ASJC Scopus subject areas
- Clinical Neurology
- Neuroscience(all)
Cite this
Romano, J. G., Rotta, F. T., Potter, P., Rosenfeld, V., Santibanez, R., Rocha, B., & Bradley, W. G. (1998). Relapses in the Guillain-Barre syndrome after treatment with intravenous immune globulin or plasma exchange. Muscle and Nerve, 21(10), 1327-1330. https://doi.org/10.1002/(SICI)1097-4598(199810)21:10<1327::AID-MUS14>3.0.CO;2-Z